Bull
$86.84
Precio del escenario
$91.810
-1.065 (-1.16%)Al cierre
Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The Company owns approximately 1,450 properties in North America and the United Kingdom. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs).
Ventas Inc appears to be a good buy right now due to its strong revenue growth of 21.7% year-over-year, reaching $1.73 billion, and a raised full-year earnings guidance to $0.58 - $0.63 per share. The current RSI is at 40.737, suggesting the stock is nearing oversold territory, which could indicate a buying opportunity. However, the main risk is the high forward P/E ratio of 151.5152, which indicates that the stock may be overvalued if earnings do not meet expectations.
BMO Capital
$107
2026-08-11
BMO Capital
2026-08-11
Precio objetivo
$107
Citi
$72
2026-08-04
Citi
2026-08-04
Precio objetivo
$72
BofA
$113
2026-08-03
BofA
2026-08-03
Precio objetivo
$113
Cantor Fitzgerald
$102
2026-07-31
Cantor Fitzgerald
2026-07-31
Precio objetivo
$102
Mizuho
$104
2026-07-22
Mizuho
2026-07-22
Precio objetivo
$104
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Ventas Releases 2025-2026 Corporate Sustainability Report

Analysis of VTR Options Contracts and Investment Opportunities

Ventas Q2 2026 Earnings Highlights

Ventas Reports Q2 Profit Growth Driven by Senior Housing

Analysis of JGLO Stock Price Fluctuations
Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The Company owns approximately 1,450 properties in North America and the United Kingdom. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs). It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).
Ventas Inc appears to be a good buy right now due to its strong revenue growth of 21.7% year-over-year, reaching $1.73 billion, and a raised full-year earnings guidance to $0.58 - $0.63 per share. The current RSI is at 40.737, suggesting the stock is nearing oversold territory, which could indicate a buying opportunity. However, the main risk is the high forward P/E ratio of 151.5152, which indicates that the stock may be overvalued if earnings do not meet expectations.
20 analysts cover VTR: 2 rate it Buy, 14 Hold and 4 Sell. The average price target is 84.21.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.